Annual report pursuant to Section 13 and 15(d)

Cover

v3.24.1
Cover - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Mar. 18, 2024
Jun. 30, 2023
Document Information Line Items      
Entity Registrant Name DERMATA THERAPEUTICS, INC.    
Entity Central Index Key 0001853816    
Document Type 10-K    
Amendment Flag false    
Entity Voluntary Filers No    
Current Fiscal Year End Date --12-31    
Entity Well Known Seasoned Issuer No    
Entity Small Business true    
Entity Shell Company false    
Entity Emerging Growth Company true    
Entity Current Reporting Status Yes    
Document Period End Date Dec. 31, 2023    
Entity Filer Category Non-accelerated Filer    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Entity Ex Transition Period true    
Entity Common Stock Shares Outstanding   6,660,840  
Entity Public Float     $ 4.8
Document Annual Report true    
Document Transition Report false    
Document Fin Stmt Error Correction Flag false    
Entity File Number 001-40739    
Entity Incorporation State Country Code DE    
Entity Tax Identification Number 86-3218736    
Entity Address Address Line 1 3525 Del Mar Heights Rd.    
Entity Address Address Line 2 322    
Entity Address City Or Town San Diego    
Entity Address State Or Province CA    
Entity Address Postal Zip Code 92130    
City Area Code 858    
Icfr Auditor Attestation Flag false    
Auditor Firm Id 659    
Local Phone Number 800-2543    
Entity Interactive Data Current Yes    
Auditor Name Moss Adams LLP    
Auditor Location San Diego, California    
Common Stock [Member]      
Document Information Line Items      
Security 12b Title Common Stock, par value $0.0001 per share    
Trading Symbol DRMA    
Security Exchange Name NASDAQ    
Warrants, exercisable for one share of Common Stock      
Document Information Line Items      
Security 12b Title Warrants, exercisable for one share of Common Stock    
Trading Symbol DRMAW    
Security Exchange Name NASDAQ